/PRNewswire-FirstCall/ -- Reliv International, Inc. (Nasdaq: RELV), a nutrition and direct selling company, recently introduced its blood-sugar management product, GlucAffect®, in
With its introduction into these Asian markets, GlucAffect is now available from Reliv independent distributors in 11 of Reliv's 15 markets. Between 12 and 19 percent of the Asian population is affected by metabolic syndrome, according to a study led by
A clinical study published in the journal
found that GlucAffect significantly reduced blood glucose levels and helped control weight in study participants.
"We believe the study results of GlucAffect represent a significant development," said Dr.
, vice chairman and chief scientific officer of Reliv, "because nutritional science increasingly is seen as a complement to traditional care and prescriptive remedies for metabolic syndrome."
GlucAffect, a powdered supplement consumed by mixing it with water or other liquids, has a unique combination of innovative ingredients. Hastings said, "Ingredients were carefully selected based upon research, extensive testing, processes and controls instituted by Reliv's team of nutritional scientists."
The clinical study included 50 overweight individuals who had pre-diabetic glucose levels prior to the study. Subjects taking GlucAffect lowered their fasting blood glucose by an average of 30 percent and they lost an average of 16 pounds. Subjects in the control group reported a marginal decline in blood glucose levels and no significant weight loss.
The study was conducted at Gabriele D'Annunzio University in Chieti-Pescara,
The participants consumed GlucAffect or a placebo four times a day for six days a week, participated in an exercise program and ate a healthy diet.